Pigmentation with doxorubicin therapy.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D004317:Doxorubicin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009260:Nail Diseases / Q000139:chemically induced*; D010859:Pigmentation Disorders / Q000139:chemically induced*
D004317:Doxorubicin; D000324:Adrenocorticotropic Hormone